Using GEPIA, an online tool for analyzing the RNA-seq expression data26, PFN2 high expression is significantly correlated with poor overall survival of prostate cancer patients in The Cancer Genome Atlas (TCGA) dataset (Supplementary Fig. S8), while SNTB1 is not. The gene discussed is PFN2; the disease is prostate carcinoma.